These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 23407755)

  • 1. Vaccination against Lyme disease: past, present, and future.
    Embers ME; Narasimhan S
    Front Cell Infect Microbiol; 2013; 3():6. PubMed ID: 23407755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lyme borreliosis vaccination: the facts, the challenge, the future.
    Schuijt TJ; Hovius JW; van der Poll T; van Dam AP; Fikrig E
    Trends Parasitol; 2011 Jan; 27(1):40-7. PubMed ID: 20594913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
    de Silva AM; Telford SR; Brunet LR; Barthold SW; Fikrig E
    J Exp Med; 1996 Jan; 183(1):271-5. PubMed ID: 8551231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of outer surface protein A by Borrelia burgdorferi during transmission from infected mammals to feeding ticks is insufficient to trigger OspA seroconversion.
    Woodman ME; Cooley AE; Stevenson B
    FEMS Immunol Med Microbiol; 2008 Nov; 54(2):277-82. PubMed ID: 18793197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tick-Tattoo: DNA Vaccination Against
    Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
    Front Immunol; 2021; 12():615011. PubMed ID: 33717102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking pathogen transmission at the source: reservoir targeted OspA-based vaccines against Borrelia burgdorferi.
    Gomes-Solecki M
    Front Cell Infect Microbiol; 2014; 4():136. PubMed ID: 25309883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks.
    Tsao J; Barbour AG; Luke CJ; Fikrig E; Fish D
    Vector Borne Zoonotic Dis; 2001; 1(1):65-74. PubMed ID: 12653137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductions in human Lyme disease risk due to the effects of oral vaccination on tick-to-mouse and mouse-to-tick transmission.
    Voordouw MJ; Tupper H; Önder Ö; Devevey G; Graves CJ; Kemps BD; Brisson D
    Vector Borne Zoonotic Dis; 2013 Apr; 13(4):203-14. PubMed ID: 23428088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
    Eschner AK; Mugnai K
    Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice.
    Meirelles Richer L; Aroso M; Contente-Cuomo T; Ivanova L; Gomes-Solecki M
    Clin Vaccine Immunol; 2011 Nov; 18(11):1809-16. PubMed ID: 21918116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against a tick protein, Salp15, protect mice from the Lyme disease agent.
    Dai J; Wang P; Adusumilli S; Booth CJ; Narasimhan S; Anguita J; Fikrig E
    Cell Host Microbe; 2009 Nov; 6(5):482-92. PubMed ID: 19917502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine.
    Straubinger RK; Dharma Rao T; Davidson E; Summers BA; Jacobson RH; Frey AB
    Vaccine; 2001 Oct; 20(1-2):181-93. PubMed ID: 11567763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of OspA monoclonal antibody C3.78 with Borrelia burgdorferi within ticks.
    Gipson CL; de Silva AM
    Infect Immun; 2005 Mar; 73(3):1644-7. PubMed ID: 15731064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination to Prevent Lyme Disease: A Movement Towards Anti-Tick Approaches.
    Johnson EE; Hart TM; Fikrig E
    J Infect Dis; 2024 Aug; 230(Supplement_1):S82-S86. PubMed ID: 39140718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
    Grosenbaugh DA; Rissi DR; Krimer PM
    Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies.
    Kurtenbach K; Dizij A; Voet P; Hauser P; Simon MM
    Vaccine; 1997 Oct; 15(15):1670-4. PubMed ID: 9364698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks.
    de Silva AM; Zeidner NS; Zhang Y; Dolan MC; Piesman J; Fikrig E
    Infect Immun; 1999 Jan; 67(1):30-5. PubMed ID: 9864192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of primary mast cells with Borrelia burgdorferi (sensu stricto): role in transmission and dissemination in C57BL/6 mice.
    Bernard Q; Wang Z; Di Nardo A; Boulanger N
    Parasit Vectors; 2017 Jun; 10(1):313. PubMed ID: 28655322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of lyme disease: promising research or sisyphean task?
    Krupka M; Zachova K; Weigl E; Raska M
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):261-75. PubMed ID: 21633917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.